Dr. Miner’s graduate research in organic chemistry focused on the development of new chemical methods for the synthesis of hydroperoxides and endocyclic peroxides using molecular oxygen as a source of oxygen atoms. Dr. Miner then used these newly discovered methods for the synthesis of biologically active small molecules as potential pharmaceutical agents. He has also conducted research in the field of supramolecular chemistry, exploring the host-guest relationships between synthetic lectins and various saccharides. As a result of his graduate work, Dr. Miner is also well-versed in a number of analytical techniques used in the pharmaceutical industry.
Matthew R. Miner, PH.D.
Matthew Miner is a science law clerk in the firm’s Litigation Department and a member of its Intellectual Property group. He contributes to the firm’s work in patent litigation, patent opinions and due diligence. Dr. Miner joined Goodwin in 2016. Dr. Miner is an editor of the firm’s Big Molecule Watch blog, which tracks developments in the biosimilars space.
Dr. Miner is currently enrolled at Suffolk University Law School.
New York University
State University of New York at Oneonta